[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Tannock, 2009 - Google Patents

Microbial succession and gut health: probiotics

Tannock, 2009

Document ID
11070105330600468961
Author
Tannock G
Publication year
Publication venue
Food‐Borne Microbes: Shaping the Host Ecosystem

External Links

Snippet

This chapter suggests ways in which knowledge of the microbial ecology of the human bowel can be obtained using modern technologies. Probiotics aimed at altering the composition of oral and vaginal ecosystems have been developed or are under …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Wasilewski et al. Beneficial effects of probiotics, prebiotics, synbiotics, and psychobiotics in inflammatory bowel disease
Adak et al. An insight into gut microbiota and its functionalities
US10967010B2 (en) Compositions comprising bacterial strains
Dunne Adaptation of bacteria to the intestinal niche: probiotics and gut disorder
Hoentjen et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation
Nagalingam et al. Role of the microbiota in inflammatory bowel diseases
Kim et al. Change of fecal flora and effectiveness of the short-term VSL# 3 probiotic treatment in patients with functional constipation
Murray et al. Fecal microbiota in sensitized wheezy and non‐sensitized non‐wheezy children: a nested case–control study
Bibiloni et al. VSL# 3 probiotic-mixture induces remission in patients with active ulcerative colitis
Shibolet et al. Variable response to probiotics in two models of experimental colitis in rats
Scott et al. Manipulating the gut microbiota to maintain health and treat disease
Kuisma et al. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora
Reid et al. New scientific paradigms for probiotics and prebiotics
Sanders Probiotics: considerations for human health
Huynh et al. Probiotic preparation VSL# 3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study
Mikelsaar et al. Lactobacillus fermentum ME-3–an antimicrobial and antioxidative probiotic
Martín et al. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models
McCarthy et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance
Doron et al. Probiotics: their role in the treatment and prevention of disease
Alvaro et al. Composition and metabolism of the intestinal microbiota in consumers and non-consumers of yogurt
Huang et al. In vitro probiotic characteristics of Lactobacillus plantarum ZDY 2013 and its modulatory effect on gut microbiota of mice
Tannock What immunologists should know about bacterial communities of the human bowel
Macfarlane et al. Mucosal biofilm communities in the human intestinal tract
Somineni et al. The microbiome in patients with inflammatory diseases
Tannock Probiotics: time for a dose of realism